Karolina Woziwodzka

Kopernika St. 15c
Krakow, MA 31501, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment.

The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment.

Journal: Medicina (Kaunas, Lithuania)

Published: February 14, 2022

Transgelin-2 in Multiple Myeloma: A New Marker of Renal Impairment?

Transgelin-2 in Multiple Myeloma: A New Marker of Renal Impairment?

Journal: Molecules (Basel, Switzerland)

Published: November 14, 2021

Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients.

Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients.

Journal: Medicina (Kaunas, Lithuania)

Published: November 14, 2021

Uremic leontiasis ossea inducing respiratory failure in a patient with stage 5 chronic kidney disease.

Uremic leontiasis ossea inducing respiratory failure in a patient with stage 5 chronic kidney disease.

Journal: Polish archives of internal medicine

Published: August 28, 2020

Gallstone ileus concurrent with cholelithiasis in a patient with stage 5 chronic kidney disease.

Gallstone ileus concurrent with cholelithiasis in a patient with stage 5 chronic kidney disease.

Journal: Polish archives of internal medicine

Published: July 10, 2020

Chronic kidney disease caused by tuberous sclerosis complex: lymphangioleiomyomatosis diagnosed in an adult woman.

Chronic kidney disease caused by tuberous sclerosis complex: lymphangioleiomyomatosis diagnosed in an adult woman.

Journal: Polish archives of internal medicine

Published: July 07, 2020

Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma.

Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma.

Journal: Mediators of inflammation

Published: June 15, 2020

New Markers of Renal Failure in Multiple Myeloma and Monoclonal Gammopathies.

New Markers of Renal Failure in Multiple Myeloma and Monoclonal Gammopathies.

Journal: Journal of clinical medicine

Published: May 03, 2020

Neutrophil-to-lymphocyte ratio predicts long-term all-cause mortality in patients with chronic kidney disease stage 5.

Neutrophil-to-lymphocyte ratio predicts long-term all-cause mortality in patients with chronic kidney disease stage 5.

Journal: Folia medica Cracoviensia

Published: January 07, 2020

Interplay of nitric oxide metabolites and markers of endothelial injury, inflammation, and vascular disease in the spectrum of advanced chronic kidney disease.

Interplay of nitric oxide metabolites and markers of endothelial injury, inflammation, and vascular disease in the spectrum of advanced chronic kidney disease.

Journal: Kardiologia polska

Published: November 21, 2019

Proteoglycan/glycosaminoglycan and collagen content in the arterial wall of patients with end-stage renal disease: new indicators of vascular disease.

Proteoglycan/glycosaminoglycan and collagen content in the arterial wall of patients with end-stage renal disease: new indicators of vascular disease.

Journal: Polish archives of internal medicine

Published: October 16, 2019

New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia.

New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia.

Journal: Journal of clinical medicine

Published: October 07, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026